Grassley receives GSK’s Paxil documents, but his concerns remain

A spokeswoman for Sen. Charles Grassley says documents submitted by GlaxoSmithKline on its drug Paxil have, at first glance, not alleviated the lawmaker’s suspicions that GSK knew about increased suicide risks associated with the antidepressant years before it sent a 2006 warning letter to physicians.

“Our concerns have not changed,” says spokeswoman Jill Kozeny.

The lawmaker received a tall stack of papers from GSK the day after his deadline for the company to submit documents on Paxil. Kozeny says Grassley’s staff is going through the documents this week and declined to comment on the next steps Grassley might be.

Read more about Grassley and GlaxoSmithKline’s missing documents here and here.


3 Responses to “Grassley receives GSK’s Paxil documents, but his concerns remain”

  1. Lynn Says:

    Time for the GSK guys to start practicing their “I’m sorry” faces. (:

  2. truthman30 Says:


    I would have thought Glaxo shredded the evidence by now… (surely that would be more their style?)

    I wonder what information these documents contain?…

  3. Lynn Says:

    I read a little of Dr. Glenmullen’s report and it is the validation I’ve been looking for. At the end of it he lists studies which have been done on akathisia and anti-depressant-induced suicidality. I hope an MP is trying to get those missing pages, too.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: